Literature DB >> 16440329

Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex.

Stacey L Payne1, Mary J C Hendrix, Dawn A Kirschmann.   

Abstract

We have previously demonstrated that lysyl oxidase (LOX) is expressed in invasive breast cancer cells compared to poorly invasive cells. Additionally, we have recently shown that LOX regulates cell migration, a key step in the invasion process, through a hydrogen peroxide-dependent mechanism involving the focal adhesion kinase (FAK)/Src signaling complex. Here we further elucidate the role of LOX in cell motility/migration by examining the role of LOX in actin filament polymerization. We demonstrate that inhibition of LOX leads to an increase in phalloidin staining, directly associated with an increase in actin stress fiber formation. This increase in staining was confirmed by activity assays showing an increase in Rho activity with decreased LOX activity. Additionally, Rac and Cdc42 activity decreased with the reduction in LOX activity. Taken together, these data demonstrate a loss of a motogenic phenotype with decreased LOX activity. Finally, in order to elucidate the mechanism by which LOX regulates actin polymerization, we have demonstrated that LOX facilitates p130(Cas) phosphorylation, which allows for the binding to CAS related kinase (Crk) and formation of the p130(Cas)/Crk/DOCK180 signaling complex. Formation of this complex leads to an increase in Rac-GTP, which decreases actin stress fiber formation and increases formation of lamellipodium. These data demonstrate that LOX regulates cell motility/migration through changes in actin filament polymerization, which involve the regulation of the p130(Cas)/Crk/DOCK180 signaling pathway. Elucidating the role of LOX in the regulation of cell motility will allow the development of more effective therapeutic strategies to treat invasive/metastatic breast cancer. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440329     DOI: 10.1002/jcb.20792

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  27 in total

Review 1.  Noncanonical TGF-β signaling during mammary tumorigenesis.

Authors:  Jenny G Parvani; Molly A Taylor; William P Schiemann
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-31       Impact factor: 2.673

2.  Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration.

Authors:  Ling Wei; Xian-Rang Song; Ju-Jie Sun; Xing-Wu Wang; Li Xie; Li-Yan Lv
Journal:  Cancer Biother Radiopharm       Date:  2012-11-09       Impact factor: 3.099

3.  The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3.

Authors:  Hui Wang; Hua Linghu; Jin Wang; Ya-ling Che; Ting-xiu Xiang; Wei-xue Tang; Zhen-wei Yao
Journal:  Tumour Biol       Date:  2009-12-23

4.  Functional consequences of mitochondrial DNA deletions in human skin fibroblasts: increased contractile strength in collagen lattices is due to oxidative stress-induced lysyl oxidase activity.

Authors:  Marc Majora; Tanja Wittkampf; Bianca Schuermann; Maren Schneider; Susanne Franke; Susanne Grether-Beck; Ekkehard Wilichowski; Françoise Bernerd; Peter Schroeder; Jean Krutmann
Journal:  Am J Pathol       Date:  2009-08-06       Impact factor: 4.307

5.  Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.

Authors:  Molly A Taylor; Jay D Amin; Dawn A Kirschmann; William P Schiemann
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

6.  Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton.

Authors:  Michael S Guerrero; J Thomas Parsons; Amy H Bouton
Journal:  Genes Cancer       Date:  2012-05

7.  Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer.

Authors:  Neill Patani; Wen Jiang; Robert Newbold; Kefah Mokbel
Journal:  J Carcinog       Date:  2010-11-12

Review 8.  The TGF-beta paradox in human cancer: an update.

Authors:  Maozhen Tian; William P Schiemann
Journal:  Future Oncol       Date:  2009-03       Impact factor: 3.404

9.  The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms.

Authors:  Zhen Lu; Robert C Bast
Journal:  Cell Adh Migr       Date:  2013-01-28       Impact factor: 3.405

10.  The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells.

Authors:  Alla Bondareva; Charlene M Downey; Fabio Ayres; Wei Liu; Steven K Boyd; Benedikt Hallgrimsson; Frank R Jirik
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.